These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16230192)

  • 1. Absidia posttraumatic infection: successful treatment with posaconazole.
    Garbino J; Uçkay I; Amini K; Puppo M; Richter M; Lew D
    J Infect; 2005 Oct; 51(3):e135-8. PubMed ID: 16230192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratitis caused by Absidia corymbifera in an immunocompetent male with no corneal injuries.
    Mesa Varona D; Celis Sánchez J; Alfaya Muñoz L; Avendaño Cantos EM; Romero Moraleda L
    Arch Soc Esp Oftalmol; 2015 Mar; 90(3):139-41. PubMed ID: 25443187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole.
    Salas V; Pastor FJ; Calvo E; Sutton D; García-Hermoso D; Mayayo E; Dromer F; Fothergill A; Alvarez E; Guarro J
    Med Mycol; 2012 Oct; 50(7):710-5. PubMed ID: 22458251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia.
    Rickerts V; Atta J; Herrmann S; Jacobi V; Lambrecht E; Bialek R; Just-Nübling G
    Mycoses; 2006; 49 Suppl 1():27-30. PubMed ID: 16961579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae.
    Kok J; Gilroy N; Halliday C; Lee OC; Novakovic D; Kevin P; Chen S
    J Infect; 2007 Sep; 55(3):e33-6. PubMed ID: 17624436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Absidia corymbifera infection in mice with amphotericin B and itraconazole.
    Mosquera J; Warn PA; Rodriguez-Tudela JL; Denning DW
    J Antimicrob Chemother; 2001 Oct; 48(4):583-6. PubMed ID: 11581243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.
    Perkhofer S; Locher M; Cuenca-Estrella M; Rüchel R; Würzner R; Dierich MP; Lass-Flörl C
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2636-8. PubMed ID: 18458135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy.
    Almannai M; Imran H; Estrada B; Siddiqui AH
    Pediatr Hematol Oncol; 2013 Apr; 30(3):184-6. PubMed ID: 23444832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy.
    Brugière O; Dauriat G; Mal H; Marrash-Chalha R; Fournier M; Groussard O; Besnard M; Lesèche G; Dupont B
    Transplantation; 2005 Nov; 80(9):1361-2. PubMed ID: 16382553
    [No Abstract]   [Full Text] [Related]  

  • 10. Absidia Corymbifera in an immune competent accident victim with multiple abdominal injuries: case report.
    Belfiori R; Terenzi A; Marchesini L; Repetto A
    BMC Infect Dis; 2007 May; 7():46. PubMed ID: 17531089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-traumatic mucormycosis due to Lichtheimia corymbifera: three case reports].
    Lambert D; Nerot C; Huguenin A; Diallo S; Mzabi A; Ohl X; Noel V; Rouger C; Strady C; Villena I; Bani-Sadr F; Toubas D
    J Mycol Med; 2014 Dec; 24(4):345-50. PubMed ID: 25467816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.
    Vigouroux S; Morin O; Moreau P; Méchinaud F; Morineau N; Mahé B; Chevallier P; Guillaume T; Dubruille V; Harousseau JL; Milpied N
    Clin Infect Dis; 2005 Feb; 40(4):e35-7. PubMed ID: 15712069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saksenaea vasiformis Orbital Cellulitis in an Immunocompetent Child Treated With Posaconazole.
    Reich P; Shute T; Lysen C; Lockhart SR; Kelly Keating M; Custer P; Orscheln R
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):e169-e171. PubMed ID: 29522137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous mucormycosis in an immunocompromised patient.
    Becker BC; Schuster FR; Ganster B; Seidl HP; Schmid I
    Lancet Infect Dis; 2006 Aug; 6(8):536. PubMed ID: 16870532
    [No Abstract]   [Full Text] [Related]  

  • 15. Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy.
    Tobón AM; Arango M; Fernández D; Restrepo A
    Clin Infect Dis; 2003 Jun; 36(11):1488-91. PubMed ID: 12766845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-traumatic fungal keratitis caused by Absidia corymbifera, with successful medical treatment.
    Narain S; Mitra M; Barton RC; Evans EG; Hutchinson C
    Eye (Lond); 2001 Jun; 15(Pt 3):352-3. PubMed ID: 11450745
    [No Abstract]   [Full Text] [Related]  

  • 17. Posaconazole for the treatment of mucormycosis.
    Enoch DA; Aliyu SH; Sule O; Lewis SJ; Karas JA
    Int J Antimicrob Agents; 2011 Dec; 38(6):465-73. PubMed ID: 21782392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful use of posaconazole in a pediatric case of fungal necrotizing fasciitis.
    De Decker K; Van Poucke S; Wojciechowski M; Ieven M; Colpaert C; Vogelaers D; Jorens PG
    Pediatr Crit Care Med; 2006 Sep; 7(5):482-5. PubMed ID: 16878050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous mucormycosis infection by Absidia in two consecutive liver transplant patients.
    García-Pajares F; Sánchez-Antolín G; Almohalla Alvárez C; Madrigal Rubiales B; Núñez-Rodríguez H; Sancho del Val L; Ruiz-Zorrilla R; Barrera A; Gómez-Nieto A; Peñas Herrero I; Vargas García A; Caro-Patón A
    Transplant Proc; 2012; 44(6):1562-4. PubMed ID: 22841214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posaconazole prophylaxis in experimental systemic zygomycosis.
    Barchiesi F; Spreghini E; Santinelli A; Fothergill AW; Pisa E; Giannini D; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2007 Jan; 51(1):73-7. PubMed ID: 17060525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.